Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1970 1
1971 1
1975 1
1979 1
1981 1
1983 3
1985 1
1986 2
1988 2
1989 1
1991 2
1992 2
1993 2
1994 1
1995 2
1996 1
1997 5
1998 1
1999 1
2000 2
2002 1
2004 2
2005 4
2006 3
2007 7
2008 7
2009 7
2010 3
2011 6
2012 2
2013 2
2014 3
2015 3
2016 2
2017 3
2018 4
2019 4
2020 9
2021 14
2022 8
2023 12
2024 22
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
A cellular model of TDP-43 induces phosphorylated TDP-43 aggregation with distinct changes in solubility and autophagy dysregulation.
Dopler MB, Abeer MI, Arezoumandan S, Cox K, Petersen TL, Daniel EH, Cannon CL 3rd, Bautista A, Blancher KD, Bland AM, Bond KJ, Davis DA, Francois JM, McCray EJ, Morgan JM, Pulliam JL, Robinson ZA, Taylor MJ, Dowell JA, Cairns NJ, Gitcho MA. Dopler MB, et al. Among authors: bland am. FEBS J. 2025 Jan 31. doi: 10.1111/febs.17413. Online ahead of print. FEBS J. 2025. PMID: 39887552
Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions.
St Peter WL, Bzowyckyj AS, Anderson-Haag T, Awdishu L, Blackman M, Bland A, Chan E, Chmielewski C, Delgado C, Eyler R, Foster C, Hudson J, Kane-Gill SL, Kliethermes MA, Le T, Madabushi R, Martin B, Miller WG, Neumiller JJ, Philbrick AM, Roberts G, Schandorf V, Webb AJ, Wu D, Nolin TD; Written on behalf of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions. St Peter WL, et al. Among authors: bland a. Am J Health Syst Pharm. 2024 Nov 18:zxae317. doi: 10.1093/ajhp/zxae317. Online ahead of print. Am J Health Syst Pharm. 2024. PMID: 39552516
154 results